BIOCOGENT, INC. – Trademark Portfolio
Entity Type: 03
BIOCOGENT, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include AVANTAGE, DERMALRX, MARIMOIST, TRIDERMOL, and TRISOOTHAL. The owner is based in STONY BROOK, NY.
25 HEALTH SCIENCES DRIVE
SUITE 206
STONY BROOK, NY 11790
Showing of trademarks Trademarks
Trademark Classifications
BIOCOGENT, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BIOCOGENT, INC. have?
BIOCOGENT, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned.
What trademark classes does BIOCOGENT, INC. file in?
BIOCOGENT, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are BIOCOGENT, INC.'s most well-known trademarks?
BIOCOGENT, INC.'s registered trademark portfolio includes well-known marks such as AVANTAGE, DERMALRX, MARIMOIST, TRIDERMOL, and TRISOOTHAL. These are among 6 currently registered trademarks in the portfolio.
What is BIOCOGENT, INC.'s trademark registration success rate?
BIOCOGENT, INC. has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.